Who
Lawrence T. Kennedy Jr.
Director and 10% owner
Company insider
Files Form 4 as: Director and 10% owner, Biodesix.
In numbers
- Trades disclosed
- 25
- Buys
- 4
- Sells
- 0
- Bought
- $12.6M
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 21 Nov 2022
- Last trade
- 2 Jan 2026
- Last filed
- 6 Jan 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Jan 2026filed 6 Jan 2026 | BDSX Biodesixoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —5,443 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | BDSX Biodesixoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —6,354 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | BDSX Biodesixoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —5,443 at $0.00 | filing |
| 2 Jan 2026filed 6 Jan 2026 | BDSX Biodesixoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —6,354 at $0.00 | filing |
| 20 May 2025filed 22 May 2025 | BDSX Biodesixoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —68,621 at $0.00 | filing |
| 20 May 2025filed 22 May 2025 | BDSX Biodesixoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —42,010 at $0.00 | filing |
| 21 Nov 2024filed 22 Nov 2024 | BDSX BiodesixDiagnostics & Labs | SEC FORM 4 Bought | $41K35,000 at $1.16 | filing |
| 6 Nov 2024filed 6 Nov 2024 | BDSX BiodesixDiagnostics & Labs | SEC FORM 4 Bought | $27K20,000 at $1.36 | filing |
| 5 Nov 2024filed 6 Nov 2024 | BDSX BiodesixDiagnostics & Labs | SEC FORM 4 Bought | $70K51,200 at $1.37 | filing |
| 23 May 2024filed 23 May 2024 | BDSX Biodesixoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —43,478 at $0.00 | filing |
| 23 May 2024filed 23 May 2024 | BDSX Biodesixoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —65,218 at $0.00 | filing |
| 23 May 2024filed 23 May 2024 | BDSX BiodesixDiagnostics & Labs | SEC FORM 4 Code M | —1,739,120 | filing |
| 23 May 2024filed 23 May 2024 | BDSX BiodesixDiagnostics & Labs | SEC FORM 4 Code M | —2,608,720 | filing |
| 21 May 2024filed 23 May 2024 | BDSX Biodesixoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —46,686 at $0.00 | filing |
| 21 May 2024filed 23 May 2024 | BDSX Biodesixoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —37,050 at $0.00 | filing |
| 5 Apr 2024filed 9 Apr 2024 | BDSX Biodesixoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | $2.0M43,478 at $46.00 | filing |
| 5 Apr 2024filed 9 Apr 2024 | BDSX Biodesixoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | $3.0M65,218 at $46.00 | filing |
| 1 Jan 2024filed 3 Jan 2024 | BDSX Biodesixoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —105,389 at $0.00 | filing |
| 3 Aug 2023filed 7 Aug 2023 | BDSX BiodesixDiagnostics & Labs | SEC FORM 4 Code A | $10.0M6,172,839 at $1.62 | filing |
| 23 May 2023filed 25 May 2023 | BDSX Biodesixoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —28,873 at $0.00 | filing |
News
Biodesix Targets 2028 Availability for AI-Assisted Lung Nodule Imaging TestBDSX · econotimes.com · 19 Oct 2026Biodesix Adds Digital Diagnostics to Lung Pipeline, Creating New Growth Platform Combining Blood and Imaging BiomarkersBDSX · manilatimes.net · 19 Oct 2026
0 headlines in the last 90 days name Lawrence T. Kennedy Jr.; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.